U.S. indices had a mixed day of trading Tuesday as investors continue to weigh an increase in COVID-19 deaths nationwide. President Biden on Thursday will lay out a six-pronged strategy aimed at stopping the spread of the Delta variant, Bloomberg reported.
Gainers
INmune Bio (NASDAQ: INMB) shares are trading higher after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging biomarkers of myelination in patients with AD.